Temperature Hypersensitivity Isolated to the Trunk
This presentation is most consistent with a neurological disorder affecting the spinothalamic tract, specifically a central cord syndrome or syringomyelia, and requires urgent neurological evaluation with MRI of the cervical and thoracic spine to identify the lesion.
Differential Diagnosis Framework
The key to understanding isolated trunk temperature hypersensitivity lies in recognizing the anatomical distribution of sensory pathways:
Primary Neurological Causes
Central cord pathology is the most likely explanation when temperature sensation is selectively affected in a truncal distribution, as the spinothalamic tract (which carries temperature and pain sensation) has a specific somatotopic organization where trunk fibers are positioned centrally within the spinal cord.
Syringomyelia should be the leading consideration, as it characteristically causes dissociated sensory loss (impaired temperature/pain with preserved light touch) in a "cape-like" or truncal distribution due to central cord cavitation interrupting crossing spinothalamic fibers.
Intramedullary spinal cord tumors (ependymomas, astrocytomas) can produce identical patterns by disrupting central cord structures before affecting peripheral white matter tracts.
Multiple sclerosis plaques affecting the cervical or thoracic cord may cause segmental temperature dysesthesias, though typically with additional neurological signs.
Critical Pitfall to Avoid
Do not confuse this presentation with peripheral neuropathy or dermatological conditions—isolated temperature hypersensitivity in a truncal distribution without limb involvement strongly localizes to the central spinal cord and demands imaging rather than EMG/NCS or skin biopsy.
Immediate Diagnostic Approach
Essential First-Line Testing
MRI of the entire spinal cord (cervical through thoracic with and without gadolinium contrast) is the definitive diagnostic test to identify structural lesions causing this symptom pattern.
Detailed sensory examination should map the exact dermatomal levels of temperature abnormality, test for dissociated sensory loss (impaired temperature/pain with preserved vibration/proprioception), and assess for associated motor weakness or hyperreflexia.
Quantitative sensory testing for thermal thresholds can objectively document the temperature hypersensitivity if the diagnosis remains unclear after imaging.
Red Flags Requiring Emergency Evaluation
Progressive weakness, bowel/bladder dysfunction, or ascending sensory level suggest acute cord compression requiring emergency neurosurgical consultation.
Acute onset with fever or systemic symptoms raises concern for transverse myelitis or spinal cord infarction.
Management Strategy
Acute Phase
Immediate neurology or neurosurgery referral is mandatory once imaging confirms a structural cord lesion, as treatment depends entirely on the underlying etiology (surgical decompression for tumors/syrinx, immunotherapy for inflammatory myelopathy, etc.).
Symptomatic Management
While awaiting definitive diagnosis and treatment:
Gabapentin (starting 300 mg three times daily, titrating to effect up to 3600 mg/day) or pregabalin (75-150 mg twice daily) can reduce neuropathic hypersensitivity symptoms.
Duloxetine (30-60 mg daily) provides an alternative for patients who cannot tolerate gabapentinoids.
Avoid attributing symptoms to anxiety or psychosomatic causes without excluding structural pathology—this is a common and dangerous diagnostic error.
Conditions to Exclude
The provided evidence discusses malignant hyperthermia 1 and rhabdomyolysis 2, but these are not relevant to isolated temperature hypersensitivity on the trunk in an awake, non-anesthetized patient. Similarly, spinal anesthesia effects 3 explain acute perioperative temperature changes but not chronic outpatient symptoms.
Prognosis and Follow-Up
Outcomes depend entirely on the underlying cause:
Syringomyelia may require surgical drainage if progressive, with variable symptom improvement.
Spinal cord tumors require oncological staging and neurosurgical resection when feasible.
Inflammatory myelopathies often respond to immunosuppression if treated early.
Serial neurological examinations every 3-6 months are essential even after initial treatment to detect progression requiring intervention adjustment.